Isohype 100 Tablet contains Isoniazid 100 mg, a widely prescribed first-line antitubercular medicine used in the prevention and treatment of tuberculosis (TB). It is commonly included in standardized DOTS therapy protocols and remains one of the most essential medications for controlling active and latent TB infection.
Isoniazid works by inhibiting the synthesis of mycolic acid, an essential component of the mycobacterial cell wall. This action helps eliminate tuberculosis bacteria and prevents the disease from spreading within the body or to others.
This strength is suitable for supervised therapy, long-term treatment plans, and preventive prophylaxis in high-risk individuals such as close contacts of TB patients. Due to its global medical relevance, the demand for Isoniazid remains consistent throughout government programs, hospitals, and private healthcare facilities.
Isohype 100 Tablet falls under the anti-infective and pulmonology segment, making it a strong-moving product for PCD franchise networks, institutional supply, and third-party manufacturing markets.